Palatin Technologies competitorsClear all
Acticor Biotech's top competitors include GBT (Global Blood Therapeutics).
| Save Comparison |  Acticor Biotech Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |
Founding Date | Founding Date 2013 | Founding Date 2012 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Paris, FR HQ Paris, FR | Locations South San Francisco, US HQ |
Employees | Employees 2310% increase | Employees 352106% increase |
Twitter followers | Twitter followers 340 | Twitter followers 1.6 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) 25 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 0.7 | Average likes per tweet (last 30 days) 3.2 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 66.67% | Percentage of tweets with engagement (last 30 days) 84% |
Alexa Website Rank | Alexa Website Rank 257693 | Alexa Website Rank 253743 |
Funding | ||
Total funding raised | Total funding raised $ 33.3m | Total funding raised $ 88.7m |
For sources of this data, please see the company profile
View company profiles
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View company